Real Estate Contracts & Agreements in the Pharmaceuticals Industry
860 Contracts & Agreements
- Lease Agreements (853 contracts from 232 companies)
- Mortgage Agreements (7 | 5)
- Acacia Diversified Holdings, Inc. (2 contracts)
- ACELRX PHARMACEUTICALS INC (5)
- Acer Therapeutics Inc. (7)
- ACHILLION PHARMACEUTICALS INC (7)
- Aclaris Therapeutics, Inc. (4)
- ACURA PHARMACEUTICALS, INC (1)
- Adamis Pharmaceuticals Corp (4)
- ADIAL PHARMACEUTICALS, INC. (1)
- Aegerion Pharmaceuticals, Inc. (9)
- Aerpio Pharmaceuticals, Inc. (3)
- AGILE THERAPEUTICS INC (5)
- Akorn (3)
- ALDER BIOPHARMACEUTICALS INC (5)
- Alexza Pharmaceuticals Inc. (1)
- ALGORX PHARMACEUTICALS INC (1)
- ALIMERA SCIENCES INC (2)
- ALSERES PHARMACEUTICALS INC (2)
- Altus Pharmaceuticals Inc. (9)
- Amag Pharmaceuticals (10)
- AmeriCann, Inc. (7)
- Ampio Pharmaceuticals, Inc. (3)
- AMYLIN PHARMACEUTICALS INC (2)
- Amylyx Pharmaceuticals, Inc. (1)
- Anacor Pharmaceuticals, Inc. (4)
- ANADYS PHARMACEUTICALS INC (2)
- Anebulo Pharmaceuticals, Inc. (1)
- Angion Biomedica Corp. (3)
- ANI Pharma Inc (8)
- Anthera Pharmaceuticals Inc (2)
- APP Pharmaceuticals, Inc. (5)
- APRICUS BIOSCIENCES, INC. (1)
- Aquestive Therapeutics, Inc. (1)
- ARADIGM CORP (1)
- Aralez Pharmaceuticals Inc. (2)
- ARIAD PHARMACEUTICALS INC (8)
- ARVINAS, INC. (10)
- Assertio Therapeutics, Inc (12)
- Atea Pharmaceuticals, Inc. (3)
- Athira Pharma, Inc. (2)
- Auspex Pharmaceuticals, Inc. (5)
- AUXILIUM PHARMACEUTICALS INC (3)
- AVADEL PHARMACEUTICALS PLC (3)
- AVANIR PHARMACEUTICALS, INC. (8)
- AYTU BIOSCIENCE, INC (9)
- BARR PHARMACEUTICALS INC (1)
- Barrel Energy Inc. (1)
- BioNumerik Pharmaceuticals, Inc. (2)
- BioPharmX Corp (6)
- Blue Water Acquisition Corp. (1)
- BODY & MIND INC. (3)
- Bohai Pharmaceuticals Group, Inc. (1)
- CADENCE PHARMACEUTICALS INC (3)
- Canbiola, Inc. (4)
- CANNAPHARMARX, INC. (1)
- Cara Therapeutics, Inc. (3)
- CASSAVA SCIENCES INC (6)
- Celator Pharmaceuticals Inc (2)
- Cerecor Inc. (2)
- CHIASMA, INC (7)
- CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
- CHINA PHARMA HOLDINGS, INC. (2)
- China Pharmaceuticals Inc (2)
- Clearside Biomedical, Inc. (2)
- CLS Holdings USA, Inc. (10)
- COGNITION THERAPEUTICS INC (4)
- COLLEGIUM PHARMACEUTICAL, INC (4)
- Columbia Care Inc. (1)
- Corcept Therapeutics Incorporated (8)
- COSMO VENTURES INC (1)
- CUBIST PHARMACEUTICALS INC (7)
- CUMBERLAND PHARMACEUTICALS INC (8)
- Cure Pharmaceutical Holding Corp. (1)
- CymaBay Therapeutics, Inc. (4)
- Cyteir Therapeutics, Inc. (3)
- DiCE MOLECULES HOLDINGS, LLC (4)
- Dova Pharmaceuticals Inc. (3)
- DURECT CORP (21)
- Edgewise Therapeutics, Inc. (1)
- Egalet Corp (1)
- Elixir Pharmaceuticals, Inc. (3)
- Eloxx Pharmaceuticals, Inc. (5)
- ENCYSIVE PHARMACEUTICALS INC (1)
- EPIX Pharmaceuticals, Inc. (6)
- Evofem Biosciences, Inc. (6)
- Evoke Pharma Inc (7)
- Evolus, Inc. (3)
- Exactus, Inc. (3)
- EyePoint Pharmaceuticals, Inc. (5)
- EYETECH PHARMACEUTICALS INC (4)
- Foamix Pharmaceuticals Ltd. (4)
- Fulcrum Therapeutics, Inc. (1)
- Furiex Pharmaceuticals, Inc. (1)
- GRAYBUG VISION, INC. (2)
- GUILFORD PHARMACEUTICALS INC (2)
- HARROW HEALTH, INC. (1)
- Horizon Pharma plc (9)
- IDENIX PHARMACEUTICALS INC (10)
- Ikena Oncology, Inc. (1)
- IMAGING3 INC (1)
- IMARA Inc. (3)
- INNOVATE BIOPHARMACEUTICALS, INC. (1)
- Innoviva, Inc. (5)
- INSPIRE PHARMACEUTICALS INC (4)
- Intersect ENT, Inc. (4)
- ISTA PHARMACEUTICALS INC (5)
- Jaguar Health, Inc. (10)
- JAVELIN PHARMACEUTICALS, INC (2)
- Jazz Pharmaceuticals plc (7)
- JUNIPER PHARMACEUTICALS INC (2)
- Jushi Holdings Inc. (10)
- Kala Pharmaceuticals, Inc. (2)
- Kaleido Biosciences, Inc. (2)
- Kaya Holdings, Inc. (5)
- KEMPHARM, INC (4)
- Lev Pharmaceuticals Inc (1)
- Level Brands, Inc. (5)
- Lexaria Bioscience Corp. (2)
- LIPELLA PHARMACEUTICALS INC (3)
- Lipocine Inc. (2)
- Liquidia Technologies Inc (2)
- Lumena Pharmaceuticals, Inc. (1)
- Lyra Therapeutics, Inc. (3)
- MAP Pharmaceuticals, Inc. (7)
- MARINUS PHARMACEUTICALS INC (2)
- MAXIM PHARMACEUTICALS INC (1)
- Medicine Man Technologies, Inc. (1)
- Menlo Therapeutics Inc. (2)
- MICROCHANNEL TECHNOLOGIES CORP (7)
- MiddleBrook Pharmaceuticals, Inc. (2)
- MILLENNIUM PHARMACEUTICALS INC (1)
- MIRA PHARMACEUTICALS, INC. (1)
- MJ BIOTECH, INC. (1)
- MJ Holdings, Inc. (6)
- Molecular Insight Pharmaceuticals, Inc. (6)
- MYnd Analytics, Inc. (2)
- MyoKardia Inc (4)
- Nabriva Therapeutics plc (2)
- NEKTAR THERAPEUTICS (3)
- Neuralstem, Inc. (2)
- NEW RIVER PHARMACEUTICALS INC (8)
- NGM BIOPHARMACEUTICALS INC (1)
- Notis Global, Inc. (1)
- NovaBay Pharmaceuticals, Inc. (7)
- Novan, Inc. (7)
- NPS PHARMACEUTICALS INC (8)
- NUCRYST Pharmaceuticals Corp. (2)
- OCULAR THERAPEUTIX, INC (5)
- OMEROS CORP (16)
- Omthera Pharmaceuticals, Inc. (1)
- OncoMed Pharmaceuticals Inc (4)
- One World Pharma, Inc. (5)
- OPIANT PHARMACEUTICALS, INC. (1)
- OPTIMER PHARMACEUTICALS INC (5)
- OSCIENT PHARMACEUTICALS CORP (1)
- OTONOMY, INC. (4)
- Pacira Pharmaceuticals, Inc. (3)
- Panacea Acquisition Corp (1)
- PANACOS PHARMACEUTICALS, INC. (3)
- Paratek Pharmaceuticals, Inc. (18)
- PEAK PHARMACEUTICALS, INC. (1)
- PENWEST PHARMACEUTICALS CO (3)
- PLIANT THERAPEUTICS, INC. (2)
- PLx Pharma Inc. (5)
- PONIARD PHARMACEUTICALS, INC. (5)
- PRAECIS PHARMACEUTICALS INC (1)
- PREDIX PHARMACEUTICALS HOLDINGS INC (5)
- Prestige Brands Holdings Inc (2)
- Processa Pharmaceuticals, Inc. (1)
- Profile Solutions, Inc. (1)
- ProPhase Labs, Inc. (3)
- Pulmatrix, Inc. (1)
- QUARK PHARMACEUTICALS INC (4)
- Ra Pharmaceuticals, Inc. (1)
- Rain Therapeutics Inc. (4)
- Rani Therapeutics Holdings, Inc. (1)
- REATA PHARMACEUTICALS INC (6)
- Recro Pharma, Inc. (1)
- Reliant Pharmaceuticals, Inc. (2)
- RELMADA THERAPEUTICS, INC. (2)
- RespireRx Pharmaceuticals Inc. (2)
- resTORbio, Inc. (16)
- Revance Therapeutics, Inc. (7)
- Rib-X Pharmaceuticals, Inc. (1)
- ROCK CREEK PHARMACEUTICALS, INC. (1)
- SALIX PHARMACEUTICALS LTD (4)
- SANCILIO PHARMACEUTICALS COMPANY, INC. (3)
- Satsuma Pharmaceuticals, Inc. (1)
- SAVIENT PHARMACEUTICALS INC (2)
- scPharmaceuticals Inc. (3)
- SenesTech, Inc. (5)
- SHAMAN PHARMACEUTICALS INC (2)
- Sienna Biopharmaceuticals, Inc. (2)
- SIGA TECHNOLOGIES INC (5)
- Sirtris Pharmaceuticals, Inc. (1)
- Sonoma Pharmaceuticals, Inc. (10)
- Strongbridge Biopharma plc (1)
- Sucampo Pharmaceuticals, Inc. (5)
- Supernus Pharmaceuticals, Inc. (10)
- TAPESTRY PHARMACEUTICALS, INC (1)
- Targeted Medical Pharma, Inc. (1)
- Tarsus Pharmaceuticals, Inc. (2)
- TAURIGA SCIENCES, INC. (1)
- Telomir Pharmaceuticals, Inc. (1)
- Terns Pharmaceuticals, Inc. (2)
- Terra Tech Corp. (1)
- TETRAGENEX PHARMACEUTICALS, INC. (1)
- TETRALOGIC PHARMACEUTICALS CORP (1)
- TETRAPHASE PHARMACEUTICALS INC (5)
- TFF Pharmaceuticals, Inc. (1)
- THAR PHARMACEUTICALS INC (1)
- The Medicines Company (4)
- TherapeuticsMD, Inc. (4)
- Theravance Biopharma, Inc. (2)
- Theseus Pharmaceuticals, Inc. (1)
- TITAN PHARMACEUTICALS INC (3)
- Trevi Therapeutics, Inc. (1)
- Tricida, Inc. (4)
- United Cannabis Corp (1)
- Urigen Pharmaceuticals, Inc. (2)
- Urovant Sciences Ltd. (1)
- Valera Pharmaceuticals Inc (3)
- Vallon Pharmaceuticals, Inc. (2)
- Ventyx Biosciences, Inc. (4)
- Verona Pharma plc (3)
- Verrica Pharmaceuticals Inc. (4)
- Viamet Pharmaceuticals Holdings LLC (1)
- Vireo Health International, Inc. (4)
- Vitae Pharmaceuticals, Inc (1)
- Vitality Biopharma, Inc. (3)
- VIVUS INC (6)
- Wave Life Sciences Ltd. (8)
- XANODYNE PHARMACEUTICALS INC (1)
- XERIS PHARMACEUTICALS INC (2)
- ZOGENIX, INC. (2)
- Zomedica Pharmaceuticals Corp. (9)
- Zynerba Pharmaceuticals, Inc. (5)
- Fifth Amendment to Lease Agreement, dated October 27, 2023, by and between IIP-NY 2 LLC and Vireo Health of New York, LLC (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
- Office Lease for Third Floor of the Companys Principal Executive Office Dated June 5, 2023 (CHINA PHARMA HOLDINGS, INC., Filed With SEC on April 1, 2024)
- Office Lease for Second Floor of the Companys Principal Executive Office Dated June 5, 2023 (CHINA PHARMA HOLDINGS, INC., Filed With SEC on April 1, 2024)
- Lease Agreement, by and between La Jolla Shores Plaza, LLC and GRI Bio Operations, Inc., dated as of March 2, 2018, for that property located at 2223 Avenida de la Playa, Suite... (Vallon Pharmaceuticals, Inc., Filed With SEC on March 28, 2024)
- Sublease dated as of December 21, 2023, by and between RVAC Medicines (US), Inc. and Lyra Therapeutics, Inc (Lyra Therapeutics, Inc., Filed With SEC on March 22, 2024)
- Lease Forbearance Agreement, dated as of March 14, 2024, by and between cbdMD, Inc. and HSKL, Inc (Level Brands, Inc., Filed With SEC on March 18, 2024)
- Agreement of Sublease, dated December 1, 2023, between CymaBay Therapeutics, Inc. and Meta Platforms, Inc (CymaBay Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Second Amendment to Lease, dated February 6, 2024, between CymaBay Therapeutics, Inc. and BMR-Pacific Research Center, LP (CymaBay Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Agreement for Shared Lease Costs, dated April 1, 2023, between Telomir Pharmaceuticals, Inc., MIRALOGX LLC, and MIRA Pharmaceuticals, Inc (Telomir Pharmaceuticals, Inc., Filed With SEC on December 14, 2023)
- Second Amendment to 200 Pine Street Office Lease, dated October 25, 2023, between Jaguar Health, Inc. and M & E, LLC (Jaguar Health, Inc., Filed With SEC on December 1, 2023)
- First Amendment to 200 Pine Street Office Lease, dated December 24, 2021, between Jaguar Health, Inc. and M & E, LLC (Jaguar Health, Inc., Filed With SEC on December 1, 2023)
- Sixth amendment to Lease between the Company and De Anza Enterprises LLC dated as of September 6, 2023 (DURECT CORP, Filed With SEC on November 14, 2023)
- First Amendment to the Lease between the Company and Westland Development Services, Inc, dated June 21, 2023 (Sonoma Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
- Boulder Lease Agreement between the Company and Westland Development Services, Inc., dated February 19, 2021 (Sonoma Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
- Notice of Lease Terms, effective as of July 26, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Rain Therapeutics Inc., Filed With SEC on November 9, 2023)
- Sixth Amendment to Standard Office Lease dated October 9, 2023, between the Company and SB Corporate Center III-IV, LLC (Evoke Pharma Inc, Filed With SEC on November 9, 2023)
- Standard Industrial/Commercial Multi-Tenant Lease Net, by and between Rani Therapeutics, LLC and BKM South Bay 240, LLC, dated as of November 1, 2023 (Rani Therapeutics Holdings, Inc., Filed With SEC on November 8, 2023)
- FOURTH AMENDMENT TO LEASE (resTORbio, Inc., Filed With SEC on November 8, 2023)
- Sixth Amendment to Lease dated August 14, 2013, between Riverside Business Green, LP and Neos Therapeutics, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Fifth Amendment to Lease dated April 5, 2010, between TIAA and Neos Therapeutics, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Fourth Amendment to Lease dated May 1, 2009, between TIAA and Neos Therapeutics, LP (formerly PFAB, LP) (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Third Amendment to Lease dated October 1, 2003, Between TIAA and PFAB, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Second Amendment to Lease dated September 4, 2003, between Teachers Insurance and Annuity Association of America and PFAB, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- First Amendment to Lease dated September 1, 2002, between Walstib, L.P. and PFAB, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Commercial Lease Agreement dated June 10, 1999, between Walstib, L.P. and Pharmafab, Inc (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Sublease Agreement by and between the Company and AMT Manufacturing Solutions, LLC dated April 27, 2023 (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
- Fourth Lease Amendment between 99 Hayden LLC and Cyteir Therapeutics, Inc., dated as of October 3, 2023 (Cyteir Therapeutics, Inc., Filed With SEC on October 5, 2023)
- Lease Agreement by and between HCP BTC, LLC and the Company, dated September 28, 2023 (PLIANT THERAPEUTICS, INC., Filed With SEC on October 3, 2023)
- Sublease Agreement, dated as of August 31, 2023, by and between scPharmaceuticals Inc. and 89 Degrees, Inc. (d/b/a Iris Concise) (scPharmaceuticals Inc., Filed With SEC on September 20, 2023)
- Addendum IV to Lease between the Company and Wescove Vacaville, LLC dated as of May 11, 2023 (DURECT CORP, Filed With SEC on August 10, 2023)
- Fourth Amendment to Lease, dated as of August 7, 2023, by and between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC as Landlord (resTORbio, Inc., Filed With SEC on August 9, 2023)
- Fourth Amendment to Sublease Agreement, dated as of May 31, 2023, between Avadel Management Corporation and R.G. Brinkmann Company (AVADEL PHARMACEUTICALS PLC, Filed With SEC on August 9, 2023)
- Amendment No. 2 to Lease Agreement dated October 15, 2019, as amended by the First Amendment to Lease Agreement, dated May 27, 2020 (REATA PHARMACEUTICALS INC, Filed With SEC on August 8, 2023)
- Lease Agreement made by and between Lipella Pharmaceuticals Inc. and Bridgeway Development Corporation, executed on July 27, 2023 (LIPELLA PHARMACEUTICALS INC, Filed With SEC on August 2, 2023)
- Sublease Agreement, dated July 21, 2023, by and between the Company and Neurocrine Biosciences (Ventyx Biosciences, Inc., Filed With SEC on July 26, 2023)
- Agreement for Shared Lease Costs, dated April 1, 2023, between MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc., and MIRALOGX, LLC (MIRA PHARMACEUTICALS, INC., Filed With SEC on July 14, 2023)
- Seventh Amendment to Lease, dated July 12, 2023, by and between Lyra Therapeutics, Inc. and ARE-480 Arsenal Street, LLC (Lyra Therapeutics, Inc., Filed With SEC on July 14, 2023)
- Third Amendment to Lease, by and between Ocular Therapeutix, Inc. and Cobalt PropCo 2020, LLC, dated June 30, 2023 (OCULAR THERAPEUTIX, INC, Filed With SEC on July 7, 2023)
- Third Amendment to Office Lease Agreement, dated March 16, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Rain Therapeutics Inc., Filed With SEC on May 11, 2023)
- First Amendment to Multi-Tenant Industrial Triple Net Lease entered into as of May 10, 2023 by and between ULF Northfield Business Center LL and Zomedica Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on May 11, 2023)
